---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-051125"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:16:07.083233+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma raises ~$61k via two convertible notes with dilutive terms

## Summary
- Dec 16 note: $22k principal ($20k proceeds), 8% interest, matures June 15, 2025; convertible at $0.0003/share (step-down to $0.0001).
- Dec 20 note: $49.2k principal ($41k proceeds), 15% one-time interest, due Oct 15, 2025; conversion at 65% of lowest 10-day trading price.
- Proceeds used for general working capital; notes are private placements under Rule 506.
- Note terms include 4.99% beneficial ownership cap and prepayment premiums up to 125% face value.

## SEC filing metadata
- accession: 0001493152-24-051125
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/0001493152-24-051125-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224051125/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-051125
- JSON: https://secwatch.observer/filing/0001493152-24-051125.json
- Plain text: https://secwatch.observer/filing/0001493152-24-051125.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.